{
    "clinical_study": {
        "@rank": "144622", 
        "arm_group": {
            "arm_group_label": "type 1 diabetes", 
            "arm_group_type": "Experimental", 
            "description": "Predictive Low Glucose Minimizer (PLGM) System"
        }, 
        "brief_summary": {
            "textblock": "This study will be conducted in a Clinical Research Center (CRC) setting and recruiting type\n      1 diabetes that are currently using an insulin pump."
        }, 
        "brief_title": "Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize Hypoglycemia", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "condition": "Type 1 Diabetes", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 1", 
                "Hypoglycemia"
            ]
        }, 
        "detailed_description": {
            "textblock": "This study is a non-randomized, uncontrolled feasibility study that looks to enroll people\n      with type 1 diabetes who are currently using an insulin pump. During the subject's\n      participation, the study staff will closely monitor the study subject in a clinical research\n      center environment for approximately 30 hours, while controller algorithm determined insulin\n      doses are delivered by an insulin pump, and utilizing continuous glucose monitoring results."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age 21-65 years\n\n          -  Type 1 diabetes mellitus for at least one year\n\n          -  Currently using an insulin infusion pump for at least the past 6 months\n\n        Exclusion Criteria:\n\n          -  Pregnancy\n\n          -  History of Diabetic Ketoacidosis (DKA) in the past six months\n\n          -  History of severe hypoglycemia (Seizure, unconsciousness) in the past 6 months"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01919385", 
            "org_study_id": "3108873,"
        }, 
        "intervention": {
            "arm_group_label": "type 1 diabetes", 
            "description": "This study is a non-randomized feasibility study enrolling type 1 diabetics who are currently using an insulin pump. Participating Investigators will closely monitor the study subject in a clinical research center environment for approximately 30 hours, while controller algorithm determined insulin doses are delivered by an insulin pump, and utilizing continuous glucose monitoring results.", 
            "intervention_name": "Predictive Low Glucose Minimizer", 
            "intervention_type": "Device", 
            "other_name": "type 1 diabetes"
        }, 
        "intervention_browse": {
            "mesh_term": "Insulin"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Type 1 diabetes", 
            "Insulin Pump"
        ], 
        "lastchanged_date": "September 17, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Santa Barbara", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "93105"
                }, 
                "name": "Samsum Diabetes Reserach Inst."
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize Hypoglycemia in Patients With Type 1 Diabetes in a Clinical Research Setting", 
        "overall_official": {
            "affiliation": "Samsum Diabetes Reserach Inst.", 
            "last_name": "Howard Zisser, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Evaluating the ability of the system to predict a fall or rise in glucose values below or above a low glucose threshold, and take the corresponding appropriate action of reducing or suspending insulin delivery in order to keep the subject's glucose above this threshold, or resuming insulin delivery at the current basal rate upon the increase of glucose above this threshold.\nAbility of the system to issue timely and accurate warnings.", 
            "measure": "Evaluate the performance of the System while the subject is under close medical supervision in the Clinical Research Center (CRC) setting", 
            "safety_issue": "Yes", 
            "time_frame": "1 week after subject is enrolled in the study"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01919385"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Understand the System's ability to safely keep the subject glucose levels within designated threshold. The subject and the device will be continuously monitored by the Principle Investigator and Algorithm Engineer to ensure proper function of the device and subject safety. All Adverse Events will be captured on the CRF.", 
            "measure": "Capturing the number of Adverse Events as a measure of assessing subject safety", 
            "safety_issue": "Yes", 
            "time_frame": "1 week after subject is enrolled in the study"
        }, 
        "source": "Animas Corporation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Animas Corporation", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}